Moonflowers Co – Trademark Portfolio

Entity Type: 03

Moonflowers Co has 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include MOONFLOWERS. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 5 (Pharmaceuticals). This trademark owner is based in Fairfax, VA.

8280 Willow Oaks Corporate Dr., Ste. 600

Fairfax, VA 22031

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Moonflowers Co's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Moonflowers Co have?

Moonflowers Co has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.

What trademark classes does Moonflowers Co file in?

Moonflowers Co files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 35 covers advertising; business management; business administration; office functions.

What are Moonflowers Co's most well-known trademarks?

Moonflowers Co's registered trademark portfolio includes well-known marks such as MOONFLOWERS. These are among 1 currently registered trademark in the portfolio.

What is Moonflowers Co's trademark registration success rate?

Moonflowers Co has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.